215 related articles for article (PubMed ID: 4262824)
1. [Neurotoxic symptoms following clioquinol (Enterovioform)].
Pannekoek JH
Ned Tijdschr Geneeskd; 1972 Sep; 116(36):1611-5. PubMed ID: 4262824
[No Abstract] [Full Text] [Related]
2. [Polyneuropathy following long-term use of clioquinol (Enterovioform)].
van Beeck JA; Scholten JB
Ned Tijdschr Geneeskd; 1972 Sep; 116(36):1621-2. PubMed ID: 4262827
[No Abstract] [Full Text] [Related]
3. [Subacute myelo-optico-neuropathy following use of large amounts of iodochlorhydroxyquinoline (Enterovioform)].
Bron HL; Korten JJ; Pinckers AJ; Majoor CL
Ned Tijdschr Geneeskd; 1972 Sep; 116(36):1615-8. PubMed ID: 4262825
[No Abstract] [Full Text] [Related]
4. Subacute myelo-optico-neuropathy (SMON)--neurotoxicity of clioquinols.
Selby G
Proc Aust Assoc Neurol; 1973; 9():23-30. PubMed ID: 4268933
[No Abstract] [Full Text] [Related]
5. Peripheral neuropathy in rats fed with clioquinol.
Jones EL; Searle CE; Smith WT
J Pathol; 1972 Jul; 107(3):P8-9. PubMed ID: 4263803
[No Abstract] [Full Text] [Related]
6. [Neurological complications in the course of treatment of acrodermatitis enteropathica with oxyquinoline derivatives].
Papuziński M; Wilmowska-Pietruszyńska A
Pediatr Pol; 1974 Nov; 49(11):1393-7. PubMed ID: 4278959
[No Abstract] [Full Text] [Related]
7. Clioquinol: time to act.
de Pinto O; Burley D
Lancet; 1977 Jun; 1(8024):1256. PubMed ID: 68347
[No Abstract] [Full Text] [Related]
8. [Serious sensory-motor neuropathy. A case of renal failure following clioquinol absorption].
Gendre JP; Barbanel C; Degos JD; Le Quintrec Y
Nouv Presse Med; 1974 Nov; 3(37):2395-8. PubMed ID: 4282135
[No Abstract] [Full Text] [Related]
9. [Epidemiological studies on subacute myelo-optico neuropathy (SMON) in the town of Yubara, Japan. 3].
Aoyama H; Oira M; Ota T; Yoshioka S; Yoshida T
Nihon Eiseigaku Zasshi; 1970 Dec; 25(5):468-71. PubMed ID: 4251106
[No Abstract] [Full Text] [Related]
10. [Analysis of the effects of chinoform on subacute myelo-optico-neuropathy (SMON)--application of linear regression analysis by logistic transformation].
Inoue N; Kuroiwa Y; Ikeda M; Yasukouchi T
Rinsho Shinkeigaku; 1974 Oct; 14(10):769-73. PubMed ID: 4282713
[No Abstract] [Full Text] [Related]
11. Is there SMON in India?
Wadia NH
Neurol India; 1973 Sep; 21(3):95-103. PubMed ID: 4274127
[No Abstract] [Full Text] [Related]
12. Neurotoxicity of clioquinol in laboratory animals.
Tateishi J; Kuroda S; Saito A; Otsuki S
Lancet; 1972 Nov; 2(7786):1095. PubMed ID: 4117427
[No Abstract] [Full Text] [Related]
13. [Subacute myelo-optico neuropathy (author's transl)].
Heilig P; Thaler A
Klin Monbl Augenheilkd; 1974 Mar; 164(3):386-8. PubMed ID: 4277280
[No Abstract] [Full Text] [Related]
14. [Subacute myelopathy during a course of treatment with clioquinol in a patient colectomized for Crohn's disease].
Fabiani F; Pompili A; Scarinci A; Sinibaldi L
Riv Neurobiol; 1978; 24(1-2):121-37. PubMed ID: 161413
[No Abstract] [Full Text] [Related]
15. [Subacute myelo-optic neuritis].
Vanĕcek J; Fink Z
Cesk Pediatr; 1979 Nov; 34(11):661-2. PubMed ID: 160840
[No Abstract] [Full Text] [Related]
16. [Subacute myelo-optic neuropathy--toxic reaction or viral disease?].
Dimov D
Lijec Vjesn; 1972 Jul; 94(7):363-6. PubMed ID: 4266549
[No Abstract] [Full Text] [Related]
17. Neurotoxicity of oxyquinolines.
Hansson O; Herxheimer A
Lancet; 1980 Jun; 1(8180):1253-4. PubMed ID: 6104069
[No Abstract] [Full Text] [Related]
18. Myelopathy after clioquinol treatment.
Osterman PO
Lancet; 1971 Sep; 2(7723):544. PubMed ID: 4105685
[No Abstract] [Full Text] [Related]
19. Subacute myelo-optico-neuropathy (SMON).
Nelson E
Ann Intern Med; 1972 Sep; 77(3):468-70. PubMed ID: 4262315
[No Abstract] [Full Text] [Related]
20. Ethnic differences in drugs and xenobiotics. Clioquinol.
Rose FC
Prog Clin Biol Res; 1986; 214():323-30. PubMed ID: 2941765
[No Abstract] [Full Text] [Related]
[Next] [New Search]
